US Sanctions Gujarat-Based Chemical Suppliers Tied to Sinaloa Cartel's Fentanyl Network

The United States has launched one of its most expansive crackdowns yet on the global synthetic opioid supply chain, imposing sweeping sanctions on a network of individuals and entities with direct links to India. At the center of the action are Gujarat-based chemical suppliers accused of shipping critical fentanyl precursors to drug cartels operating in Mexico and Guatemala.

The US Treasury Department's Office of Foreign Assets Control (OFAC) announced sanctions against 23 individuals and entities connected to the Sinaloa Cartel, a move that places India squarely within the crosshairs of Washington's intensifying campaign against illicit drug trafficking networks. The sanctions target the full length of the supply chain — from chemical manufacturers and brokers to cartel-affiliated traffickers — who together enable the production and distribution of synthetic opioids that ultimately flood American streets.

India-Based Operators Named in US Treasury Action

Among those designated by the US Treasury are Satishkumar Hareshbhai Sutaria, a Gujarat-based pharmaceutical chemicals supplier, and his associate Yuktakumari Ashishkumar Modi. According to US authorities, the two played a central role in facilitating shipments of fentanyl precursor chemicals — most notably N-Boc-4-Piperidone — to recipients in Mexico and Guatemala. To avoid detection by customs and regulatory agencies, these shipments were systematically mislabeled as 'safe chemicals.'

Sutaria and Modi operated through two companies: SR Chemicals and Pharmaceuticals and Agrat Chemicals and Pharmaceuticals. Both individuals were arrested by Indian authorities in March 2025, representing a significant milestone in bilateral law enforcement cooperation between India and the United States in tackling transnational drug crime.

Global Brokers and India-Linked Supply Chains Under Scrutiny

The US sanctions also shine a light on foreign brokers who relied on India-based chemical firms to source precursor materials for cartel use. Jaime Augusto Barrientos Camaz, a Guatemala City-based broker, is accused of procuring chemicals from both Agrat Chemicals and SR Chemicals. Over a span of just two months, his business routed at least 116 kilograms of N-Boc-4-Piperidone — a key building block in fentanyl synthesis — through Guatemala.

In Mexico, Maria Viridiana Rugerio Arriaga was identified as another broker who sourced precursor chemicals from Indian suppliers and channeled them to drug producers manufacturing both fentanyl and methamphetamine. Her role illustrates how deeply India-linked chemical supply chains have been embedded within the global narcotics production ecosystem.

A Network That Spans Continents

The broader network described by OFAC stretches across multiple continents, with cartels leveraging supply chains that originate in Asia — particularly India and other parts of the region — to manufacture synthetic drugs at industrial scale.

These substances are then trafficked into the United States, where the fentanyl crisis continues to claim tens of thousands of lives each year.

By targeting the entire supply chain rather than just end distributors, the Treasury Department signals a strategic shift in how Washington intends to combat the opioid epidemic — by cutting off the chemical inputs that make large-scale drug manufacturing possible in the first place.

India-US Enforcement Partnership Draws Praise

The US Embassy in India acknowledged the cooperation publicly, posting on X: 'The United States deeply appreciates our partnership with Indian law enforcement, which was instrumental in disrupting key elements of this criminal network distributing precursor chemicals to cartels that manufacture and traffic illegal drugs into the United States.'

The statement underscores a growing dimension of the India-US strategic relationship — one that extends beyond trade, defense, and technology into the realm of transnational crime and narcotics enforcement. The arrest of Sutaria and Modi by Indian authorities months before the formal US sanctions announcement suggests that coordination between the two governments had been underway for some time.

Implications for India's Chemical Export Sector

The case raises broader questions about oversight and compliance within India's pharmaceutical and specialty chemicals export industry. India is one of the world's largest producers and exporters of bulk chemicals and pharmaceutical intermediates, supplying markets across North America, Europe, and beyond. While the vast majority of these exports are entirely legitimate, cases like this highlight vulnerabilities in supply chain due diligence — particularly for dual-use chemicals that have both industrial applications and potential for misuse in drug synthesis.

For businesses operating in the Indian chemicals and pharma space, the episode serves as a stark reminder of the reputational, legal, and geopolitical risks that come with inadequate end-user verification and export compliance practices. Regulators and industry bodies may face increased pressure to tighten monitoring of precursor chemical shipments in the wake of this action.

Washington's Broader Anti-Cartel Strategy

This latest sanctions round is part of a wider US policy push to dismantle the financial and logistical infrastructure of drug cartels by targeting upstream actors in their supply chains. Rather than focusing solely on interdiction at the border, the Treasury Department's approach involves identifying and cutting off the global networks of suppliers, brokers, and enablers who make large-scale synthetic drug production economically viable.

India's emergence as both a source country for precursor chemicals and an active enforcement partner in disrupting illicit trade reflects the complex and evolving role the country plays in global supply chains — one that carries both economic opportunity and significant responsibility.